Intel’s Two-Front War: A Chinese Rival Surges While a $12.5 Billion Accounting Charge Sinks the Stock

Intel's stock plunges 33% in a month as CXMT IPO surpasses its market cap and Arm enters server chips, despite 143% yearly gains.

Intel’s stock is caught in a tug-of-war between operational momentum and a perfect storm of headwinds that have erased more than a third of its value in weeks. The semiconductor giant closed Tuesday at €76.47 in European trading, shedding 5.07% on the day alone, extending a monthly slide of 33.67% and a weekly loss of 17.42%. Yet for investors who have held on for the full year, the picture is radically different: shares remain up 143.54% since January and have surged 328.93% over the past twelve months.

That disconnect between short-term pain and long-term gain captures the tension gripping Intel right now. The selloff is real, but so is the underlying business recovery — and the two narratives are colliding with unusual force.

A Chinese Competitor Just Got Much Bigger

The most immediate shock to Intel’s valuation came from across the Pacific. ChangXin Memory Technologies (CXMT) made its Shanghai stock market debut with a bang, its shares soaring more than 460%. That rally has pushed CXMT’s market capitalization past Intel’s, which currently stands at approximately €409.36 billion.

This is no mere footnote from Asia. The IPO signals a tectonic shift in the global semiconductor hierarchy, and it arrives alongside reports that Chinese manufacturers have achieved a breakthrough in mass-producing DUV lithography equipment — a technology long considered one of the last moats protecting Western chipmakers. If that barrier crumbles, Intel’s ambitious foundry strategy faces a fundamentally more competitive landscape, and the market is pricing that risk in real time.

Arm Opens a Second Front

Compounding the China anxiety, Arm Holdings is preparing to sell its own chips, directly targeting the red-hot market for AGI processors. Reports indicate Meta has already signed on as a major customer for Arm’s new 136-core processors.

The move threatens Intel at its most vulnerable point: the server market, long a duopoly shared with AMD. The irony is sharp. Intel’s Data Center and AI (DCAI) division just reported a 59% revenue surge to $6.3 billion, driven by cloud providers and Xeon 6 processor demand. That recovery story is now being overshadowed by the prospect of a powerful new competitor.

A broader fatigue with the AI narrative on Nasdaq is also weighing on sentiment. Futures on the tech-heavy index slipped 0.9% on Tuesday, and reports of multi-billion-dollar, sometimes circular financing deals between Nvidia and OpenAI have raised questions about whether the industry’s spending spree is sustainable. For Intel, any slowdown in cloud capital expenditure would strike at the heart of its turnaround.

The $12.5 Billion Distortion

Beneath the price action lies a financial anomaly that has spooked investors. Intel reported a GAAP net loss of more than $11 billion, but CFO Dave Zinsner was quick to explain that the red ink is almost entirely a non-cash charge of $12.5 billion — a revaluation of the U.S. government’s equity stake in Intel under the CHIPS Act.

“This is purely an accounting adjustment,” Zinsner emphasized, “and says nothing about our actual manufacturing or sales performance.” The operational business and the balance-sheet effect are moving in opposite directions, a pattern that has clearly unsettled the market.

Meanwhile, CEO Lip-Bu Tan is doubling down on the company’s future. Intel has raised its 2026 capital expenditure forecast from $17-18 billion to more than $20 billion, citing demand for AI compute power “unlike anything the company has experienced.” At the center of this spending spree is the 18A manufacturing process, now officially in mass production with over 400 chip designs already in development for the next generation of Series 3 products.

A new partnership with Cadence Design Systems — described by Intel executives as a historic turning point — adds further credibility to the foundry ambitions.

Technical Damage Meets Analyst Optimism

The chart tells a story of exhaustion, not collapse. Intel’s 14-day RSI has fallen to 34.0, approaching oversold territory without yet crossing the threshold. The stock now sits 23.70% below its 50-day moving average of €100.22 — a gap that historically has not persisted for long. From its 52-week high of €124.58, the shares have retreated 38.62%.

Yet analysts remain remarkably bullish. The average price target stands at €101.67, implying a 32.9% upside from current levels. That chasm between market panic and professional estimates has rarely been wider.

On Tuesday, mimik launched its “Device-First Agentic AI Infrastructure” for Intel platforms, integrating its toolsets directly into the hardware to bolster Intel’s “Private AI” capabilities. The company now says roughly 70% of its total revenue comes from AI-adjacent businesses.

The critical question is whether Intel can stabilize above its 100-day moving average of €80.40. If it cannot, the volatility — annualized at over 80% — will likely remain the dominant theme. The operational recovery is real, but the market is demanding proof that Intel can navigate a world where Chinese rivals are growing, Arm is attacking, and the AI spending cycle may be approaching a turning point.